Recent

% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

  • stockmasterp stockmasterp Jan 28, 2013 2:51 PM Flag

    Keryx Biopharmaceuticals Inc. (KERX) nearly doubled its market value Monday after a successful late-stage study of its kidney-disease drug Zerenex also showed the surprise benefit of significantly reducing the use of costly anemia treatments.

    Keryx Biopharmaceuticals Inc. (KERX) nearly doubled its market value Monday after a successful late-stage study of its kidney-disease drug Zerenex also showed the surprise benefit of significantly reducing the use of costly anemia treatments.

    Sentiment: Strong Buy

 
KERX
6.76+0.54(+8.68%)Jun 29 4:00 PMEDT